Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
Minnesota jury says Johnson & Johnson owes $65.5 million to woman with cancer who used talcum powder- Becoming amazing at Systems administration: Individual and Expert Tips
- 2 new malaria treatments announced as drug resistance grows
- Wolf bites woman in a shopping area in Germany's 2nd-biggest city
- How did this 20-light-year-wide 'Diamond Ring' form in space? Maybe a cosmic bubble burst
- The Best 10 Innovation Developments of the Year
- Discovery off Israel’s coast reveals earliest known 2,600-year-old shipment of raw iron
- Startled Venezuelans express relief but also fear after Maduro arrest
- Hundreds of Intact Dinosaur Eggs Emerge From 72-Million-Year Time Capsule
